Je was op zoek naar: astmapatienter (Deens - Engels)

pneumoni hos astmapatienter
pneumonia in patients with asthma

acetylsalisylsyre- overfølsomme astmapatienter.
acetylsalicylic acid-sensitive asthmatic patients.

hyppigheden af pneumoni hos astmapatienter var almindelig ved den højeste dosering.
the incidence of pneumonia in patients with asthma was common at the higher dose.

bisphosphonater har været forbundet med bronchokonstriktion hos acetylsalisylsyre-overfølsomme astmapatienter.
of other bisphosphonates has been associated with broncho-constriction in acetylsalicylic acid-sensitive asthmatic patients.

astmapatienter er i mindre grad udsat for systemisk påvirkning efter inhalation af fluticasonpropionat.
in patients with asthma a lesser degree of systemic exposure to inhaled fluticasone propionate has been observed.

behandling med seretide bør ikke seponeres pludseligt hos astmapatienter på grund af risiko for forværring.
seretide diskus should not be used to treat acute asthma symptoms for which a fast and short acting bronchodilator is required.

bronkial hypersekretion, astmaanfald hos astmapatienter eller patienter, der tidligere har haft astma, hoste
bronchial hypersecretion, asthma attack in asthmatic patients or patients with a history of asthma, cough

astmapatienter og patienter med kol er i mindre grad udsat for systemisk påvirkning efter inhalation af fluticasonpropionat.
in patients with asthma or copd a lesser degree of systemic exposure to inhaled fluticasone propionate has been observed.

lægen skal være opmærksom på, at hos astmapatienter er fluticasonpropionat dobbelt så effektivt som andre steroider til inhalation.
in the event of once daily dosing when the patient has a history of nocturnal symptoms the dose should be given at night and when the patient has a history of mainly day-time symptoms the dose should be given in the morning.

astmapatienter, der begynder på glucosamin - behandling bør derfor være opmærksomme på en potentiel forværring af symptomer.
asthmatic patients starting on glucosamine should therefore be aware of potential worsening of symptoms.

endvidere bor der træffes foranstaltninger med henblik på at udbrede oplysning om mulige reaktioner på sulphiter i levnedsmidler og drikkevarer til læger og astmapatienter.
in addition, action should be taken to disseminate information about possible reactions to sulphites in foods and beverages to the medical profession anti those suffering from asthma.

i det kliniske udviklingsprogram med astmapatienter blev der i alt inkluderet 7.034 patienter, som danner basis for en samlet vurdering af bivirkninger.
in the asthma clinical development program a total of 7,034 patients were included in an integrated assessment of adverse reactions.

at indånde smog, især hvis det sker ofte og langvarigt, kan have meget skadelige følger for helbredet, især hos børn, ældre og astmapatienter.
it is then up to the govern ments to decide on the composition of their national delegations, and their decision is accepted by the commission, even in cases where a delegation includes representatives of industry.

1750 pædiatriske astmapatienter i alderen 6- 14 år, og • 4 mg tyggetabletter hos 851 pædiatriske patienter i alderen 2- 5 år.
10 mg film-coated tablets in approximately 4000 adult patients 15 years of age and older 5 mg chewable tablets in approximately 1750 paediatric patients 6 to 14 years of age, and 4 mg chewable tablets in 851 paediatric patients 2 to 5 years of age.

hvis den valgte dosis viani ikke giver tilstrækkelig effekt, bør patienten også undersøges af lægen for eventuelt behov for øget steroiddosis.behandling med viani bør ikke seponeres pludseligt hos astmapatienter på grund af risiko for forværring.
possible systemic effects include cushing 's syndrome, cushingoid features, adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract and glaucoma.

hos astmapatienter var halveringstiden for serumelimination for omalizumab gennemsnitligt 26 dage med en tilsyneladende gennemsnitlig clearance på 2, 4 ± 1, 1 ml/ kg/ dagligt.
in asthma patients the omalizumab serum elimination half-life averaged 26 days, with apparent clearance averaging 2.4 ± 1.1 ml/ kg/ day.

i en samlet analyse af 11 studier med astmapatienter (7.034 patienter) var forekomsten af frakturer <1 % og oftest forbundet med et traume.
in an integrated analysis of 11 studies in asthma (7,034 patients), the incidence of fractures was <1%, and usually associated with trauma.

jeg har siddet på sygehuset om natten med en astmatisk halvandetårig, der var lige ved at blive kvalt, med venteværelser fulde af børn, hvor lægerne kunne forklare, at antallet af astmapatienter i amsterdam er steget fjorten gange inden for det sidste tiår, og det siges, at dette alt sammen skyldes luftforureningen, som bilen er en klar årsag til.
i have sat up at night in hospital with a one and a half year-old almost suffocating from asthma, with waiting rooms full of children where the doctors told me that the number of asthma patients in amsterdam had increased tenfold over the last decade, and people say that all this has to do with the air pollution, of which cars are clearly a cause.